BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

226 related articles for article (PubMed ID: 11094079)

  • 1. The MN1-TEL fusion protein, encoded by the translocation (12;22)(p13;q11) in myeloid leukemia, is a transcription factor with transforming activity.
    Buijs A; van Rompaey L; Molijn AC; Davis JN; Vertegaal AC; Potter MD; Adams C; van Baal S; Zwarthoff EC; Roussel MF; Grosveld GC
    Mol Cell Biol; 2000 Dec; 20(24):9281-93. PubMed ID: 11094079
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MN1-TEL myeloid oncoprotein expressed in multipotent progenitors perturbs both myeloid and lymphoid growth and causes T-lymphoid tumors in mice.
    Kawagoe H; Grosveld GC
    Blood; 2005 Dec; 106(13):4278-86. PubMed ID: 16081688
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Translocation (12;22) (p13;q11) in myeloproliferative disorders results in fusion of the ETS-like TEL gene on 12p13 to the MN1 gene on 22q11.
    Buijs A; Sherr S; van Baal S; van Bezouw S; van der Plas D; Geurts van Kessel A; Riegman P; Lekanne Deprez R; Zwarthoff E; Hagemeijer A
    Oncogene; 1995 Apr; 10(8):1511-9. PubMed ID: 7731705
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MN1-TEL, the product of the t(12;22) in human myeloid leukemia, immortalizes murine myeloid cells and causes myeloid malignancy in mice.
    Carella C; Bonten J; Rehg J; Grosveld GC
    Leukemia; 2006 Sep; 20(9):1582-92. PubMed ID: 16810199
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Establishment of a novel human myeloid leukemia cell line, AMU-AML1, carrying t(12;22)(p13;q11) without chimeric MN1-TEL and with high expression of MN1.
    Gotou M; Hanamura I; Nagoshi H; Wakabayashi M; Sakamoto N; Tsunekawa N; Horio T; Goto M; Mizuno S; Takahashi M; Suganuma K; Yamamoto H; Hiramatsu A; Watarai M; Shikami M; Imamura A; Mihara H; Taki T; Miwa H; Taniwaki M; Nitta M
    Genes Chromosomes Cancer; 2012 Jan; 51(1):42-53. PubMed ID: 21965128
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The MN1-TEL myeloid leukemia-associated fusion protein has a dominant-negative effect on RAR-RXR-mediated transcription.
    van Wely KH; Meester-Smoor MA; Janssen MJ; Aarnoudse AJ; Grosveld GC; Zwarthoff EC
    Oncogene; 2007 Aug; 26(39):5733-40. PubMed ID: 17369854
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Conditional MN1-TEL knock-in mice develop acute myeloid leukemia in conjunction with overexpression of HOXA9.
    Kawagoe H; Grosveld GC
    Blood; 2005 Dec; 106(13):4269-77. PubMed ID: 16105979
    [TBL] [Abstract][Full Text] [Related]  

  • 8. TEL/AML1 shows dominant-negative effects over TEL as well as AML1.
    Gunji H; Waga K; Nakamura F; Maki K; Sasaki K; Nakamura Y; Mitani K
    Biochem Biophys Res Commun; 2004 Sep; 322(2):623-30. PubMed ID: 15325275
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The leukemia-associated fusion protein MN1-TEL blocks TEL-specific recognition sequences.
    ter Haar WM; Meester-Smoor MA; van Wely KH; Schot CC; Janssen MJ; Geverts B; Bonten J; Grosveld GC; Houtsmuller AB; Zwarthoff EC
    PLoS One; 2012; 7(9):e46085. PubMed ID: 23049943
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fatal myeloproliferation, induced in mice by TEL/PDGFbetaR expression, depends on PDGFbetaR tyrosines 579/581.
    Tomasson MH; Sternberg DW; Williams IR; Carroll M; Cain D; Aster JC; Ilaria RL; Van Etten RA; Gilliland DG
    J Clin Invest; 2000 Feb; 105(4):423-32. PubMed ID: 10683371
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evidence for position effects as a variant ETV6-mediated leukemogenic mechanism in myeloid leukemias with a t(4;12)(q11-q12;p13) or t(5;12)(q31;p13).
    Cools J; Mentens N; Odero MD; Peeters P; Wlodarska I; Delforge M; Hagemeijer A; Marynen P
    Blood; 2002 Mar; 99(5):1776-84. PubMed ID: 11861295
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A new ETV6/TEL partner gene, ARG (ABL-related gene or ABL2), identified in an AML-M3 cell line with a t(1;12)(q25;p13) translocation.
    Iijima Y; Ito T; Oikawa T; Eguchi M; Eguchi-Ishimae M; Kamada N; Kishi K; Asano S; Sakaki Y; Sato Y
    Blood; 2000 Mar; 95(6):2126-31. PubMed ID: 10706884
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Two unbalanced translocations, t(12;22)(p13;q11) and t(12;?)(p13;?), in an aggressive chronic B-cell leukemia: TEL gene analysis using FISH.
    Conchon M; McManus AP; Min T; Maljaie SH; Crawford A; Brito-Babapulle V; Matutes E; Catovsky D
    Cancer Genet Cytogenet; 1997 Jun; 95(2):137-40. PubMed ID: 9169030
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Both TEL and AML-1 contribute repression domains to the t(12;21) fusion protein.
    Fenrick R; Amann JM; Lutterbach B; Wang L; Westendorf JJ; Downing JR; Hiebert SW
    Mol Cell Biol; 1999 Oct; 19(10):6566-74. PubMed ID: 10490596
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fusion of ETV6 to neurotrophin-3 receptor TRKC in acute myeloid leukemia with t(12;15)(p13;q25).
    Eguchi M; Eguchi-Ishimae M; Tojo A; Morishita K; Suzuki K; Sato Y; Kudoh S; Tanaka K; Setoyama M; Nagamura F; Asano S; Kamada N
    Blood; 1999 Feb; 93(4):1355-63. PubMed ID: 9949179
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Recruitment of the nuclear receptor corepressor N-CoR by the TEL moiety of the childhood leukemia-associated TEL-AML1 oncoprotein.
    Guidez F; Petrie K; Ford AM; Lu H; Bennett CA; MacGregor A; Hannemann J; Ito Y; Ghysdael J; Greaves M; Wiedemann LM; Zelent A
    Blood; 2000 Oct; 96(7):2557-61. PubMed ID: 11001911
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Overexpression of TEL-MN1 Fusion Enhances Resistance of HL-60 Cells to Idarubicin.
    Gong S; Guo M; Tang G; Yang J; Qiu H
    Chemotherapy; 2018; 63(6):308-314. PubMed ID: 30840968
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fusion of a novel gene, BTL, to ETV6 in acute myeloid leukemias with a t(4;12)(q11-q12;p13).
    Cools J; Bilhou-Nabera C; Wlodarska I; Cabrol C; Talmant P; Bernard P; Hagemeijer A; Marynen P
    Blood; 1999 Sep; 94(5):1820-4. PubMed ID: 10477709
    [TBL] [Abstract][Full Text] [Related]  

  • 19. TEL gene is involved in myelodysplastic syndromes with either the typical t(5;12)(q33;p13) translocation or its variant t(10;12)(q24;p13).
    Wlodarska I; Mecucci C; Marynen P; Guo C; Franckx D; La Starza R; Aventin A; Bosly A; Martelli MF; Cassiman JJ
    Blood; 1995 May; 85(10):2848-52. PubMed ID: 7742547
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The t(1;12)(q21;p13) translocation of human acute myeloblastic leukemia results in a TEL-ARNT fusion.
    Salomon-Nguyen F; Della-Valle V; Mauchauffe M; Busson-Le Coniat M; Ghysdael J; Berger R; Bernard OA
    Proc Natl Acad Sci U S A; 2000 Jun; 97(12):6757-62. PubMed ID: 10829078
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.